NM_020371.3:c.191G>A

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_020371.3(AVEN):​c.191G>A​(p.Gly64Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000605 in 1,157,894 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000040 ( 0 hom., cov: 32)
Exomes 𝑓: 9.9e-7 ( 0 hom. )

Consequence

AVEN
NM_020371.3 missense

Scores

1
3
14

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.44

Publications

0 publications found
Variant links:
Genes affected
AVEN (HGNC:13509): (apoptosis and caspase activation inhibitor) Involved in negative regulation of apoptotic process. Located in membrane. [provided by Alliance of Genome Resources, Apr 2022]
CHRM5 (HGNC:1954): (cholinergic receptor muscarinic 5) The muscarinic cholinergic receptors belong to a larger family of G protein-coupled receptors. The functional diversity of these receptors is defined by the binding of acetylcholine and includes cellular responses such as adenylate cyclase inhibition, phosphoinositide degeneration, and potassium channel mediation. Muscarinic receptors influence many effects of acetylcholine in the central and peripheral nervous system. The clinical implications of this receptor are unknown; however, stimulation of this receptor is known to increase cyclic AMP levels. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.1390141).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_020371.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AVEN
NM_020371.3
MANE Select
c.191G>Ap.Gly64Glu
missense
Exon 1 of 6NP_065104.1Q9NQS1
CHRM5
NM_012125.4
MANE Select
c.-407-7684C>T
intron
N/ANP_036257.1P08912
CHRM5
NM_001320917.2
c.-75-23787C>T
intron
N/ANP_001307846.1P08912

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AVEN
ENST00000306730.8
TSL:1 MANE Select
c.191G>Ap.Gly64Glu
missense
Exon 1 of 6ENSP00000306822.3Q9NQS1
CHRM5
ENST00000383263.7
TSL:2 MANE Select
c.-407-7684C>T
intron
N/AENSP00000372750.5P08912
CHRM5
ENST00000557872.1
TSL:1
c.-76+20391C>T
intron
N/AENSP00000453745.1P08912

Frequencies

GnomAD3 genomes
AF:
0.0000402
AC:
6
AN:
149286
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000146
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
9.91e-7
AC:
1
AN:
1008608
Hom.:
0
Cov.:
29
AF XY:
0.00
AC XY:
0
AN XY:
478624
show subpopulations
African (AFR)
AF:
0.0000515
AC:
1
AN:
19418
American (AMR)
AF:
0.00
AC:
0
AN:
6264
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
10510
East Asian (EAS)
AF:
0.00
AC:
0
AN:
18198
South Asian (SAS)
AF:
0.00
AC:
0
AN:
20056
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
16692
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2476
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
877322
Other (OTH)
AF:
0.00
AC:
0
AN:
37672
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000402
AC:
6
AN:
149286
Hom.:
0
Cov.:
32
AF XY:
0.0000412
AC XY:
3
AN XY:
72806
show subpopulations
African (AFR)
AF:
0.000146
AC:
6
AN:
41120
American (AMR)
AF:
0.00
AC:
0
AN:
15016
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3420
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5160
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9534
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
312
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
66926
Other (OTH)
AF:
0.00
AC:
0
AN:
2052
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000189

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.32
BayesDel_addAF
Benign
-0.086
T
BayesDel_noAF
Benign
-0.36
CADD
Benign
21
DANN
Uncertain
0.99
DEOGEN2
Benign
0.025
T
Eigen
Benign
-0.29
Eigen_PC
Benign
-0.28
FATHMM_MKL
Benign
0.46
N
LIST_S2
Benign
0.29
T
M_CAP
Uncertain
0.10
D
MetaRNN
Benign
0.14
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.5
L
PhyloP100
2.4
PrimateAI
Pathogenic
0.90
D
PROVEAN
Benign
0.20
N
REVEL
Benign
0.020
Sift
Benign
0.26
T
Sift4G
Uncertain
0.023
D
Polyphen
0.62
P
Vest4
0.16
MutPred
0.37
Gain of solvent accessibility (P = 0.0411)
MVP
0.58
MPC
0.00095
ClinPred
0.52
D
GERP RS
2.1
PromoterAI
0.064
Neutral
Varity_R
0.053
gMVP
0.11

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1002922620; hg19: chr15-34331057; API